Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Preferred Shares Issued Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt repayments

Hims & Hers Health (HIMS) Shares Repurchased (2021 - 2025)

Hims & Hers Health (HIMS) has disclosed Shares Repurchased for 4 consecutive years, with $80.5 million as the latest value for Q4 2025.

Quarterly Shares Repurchased rose 1508.01% to $80.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $90.0 million through Dec 2025, up 8.33% year-over-year, with the annual reading at $90.0 million for FY2025, 8.33% up from the prior year.
Shares Repurchased hit $80.5 million in Q4 2025 for Hims & Hers Health, up from $9.5 million in the prior quarter.
In the past five years, Shares Repurchased ranged from a high of $80.5 million in Q4 2025 to a low of -$22.0 million in Q4 2021.
Historically, Shares Repurchased has averaged $19.4 million across 4 years, with a median of $19.9 million in 2024.
Biggest YoY gain for Shares Repurchased was 1508.01% in 2025; the steepest drop was 68.44% in 2025.
Year by year, Shares Repurchased stood at -$22.0 million in 2021, then surged by 109.08% to $2.0 million in 2023, then skyrocketed by 150.38% to $5.0 million in 2024, then surged by 1508.01% to $80.5 million in 2025.
Business Quant data shows Shares Repurchased for HIMS at $80.5 million in Q4 2025, $9.5 million in Q3 2025, and $5.0 million in Q4 2024.